Table 1 Demographic, baseline clinical and substance using characteristics.

From: Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia

 

Active (n = 9)

Sham (n = 10)

Age (years)

34.78 ± 3.45

29.10 ± 1.70

Race (C/A/H/Ob/M)a

5/3/1/0/0

4/3/0/1/2

Gender (M/F)

9/0

9/1

Education (years)

13.56 ± 0.87

12.35 ± 0.52

WTAR IQ Score

105.89 ± 3.08

105.20 ± 1.88

TOMM (Trial 2)

49.44 ± 0.24

49.90 ± 0.10

Diagnosis (schizophrenia/schizoaffective disorder)

7/2

7/3

Age of Diagnosis

23.89 ± 1.57

20.40 ± 2.07

Antipsychotics(ATYP/TYP/Both)a

6/1/2

7/3/0

PANSS (Positive)

13.56 ± 3.32

10.60 ± 3.53

PANSS (Negative)

15.44 ± 4.67

14.10 ± 4.61

PANSS (General)

25.11 ± 4.43

23.90 ± 4.20

PANSS Total

54.11 ± 9.69

48.60 ± 4.79

C-SSRS

0.67 ± 0.29

0.40 ± 0.31

CDSS

2.33 ± 0.83

1.90 ± 0.64

Tobacco smoker (Yes/No)

8/1

8/2

Expired carbon monoxide level (ppm)

9.33 ± 2.48

15.60 ± 4.80

Cigarettes per day

7.16 ± 2.72

8.72 ± 2.95

FTND

2.56 ± 0.65

3.90 ± 1.04

Alcoholic drinks per day

0.46 ± 0.18

0.26 ± 0.18

AUDITc

3.60 ± 1.08

4.00 ± 0.97

Caffeinated drinks per day

2.44 ± 0.59

2.36 ± 0.76

% Tobacco mixed with cannabis

23.89 ± 7.06

18.20 ± 6.16

Age of first cannabis use

16.33 ± 0.93

15.90 ± 0.72

Age of first regular cannabis use

19.33 ± 0.99

17.20 ± 0.84

# of Cannabis quit attempts

1.67 ± 0.47

2.40 ± 1.23

Method of administration (joint/pipe/blunt/bong/more than one)

5/0/1/0/3

3/1/0/2/4

CUD Severity (moderate/severe)

4/5

4/6

MCL

8.00 ± 0.24

7.70 ± 0.15

CUDIT-R

16.11 ± 1.91

18.10 ± 2.04

URICA

8.30 ± 0.85

8.81 ± 0.79

Joint years

10.37 ± 2.61

6.59 ± 1.47

Cannabis grams per day

0.77 ± 0.13

0.85 ± 0.19

NarcoCheck (ng/mL)

418.67 ± 76.86

391.80 ± 73.81

MWC

10.56 ± 2.44

6.90 ± 0.99

MCQ1

8.33 ± 1.79

8.70 ± 1.89

MCQ2

9.56 ± 1.93

10.80 ± 1.87

MCQ3

12.11 ± 2.00

11.60 ± 2.01

MCQ4

11.78 ± 2.18

13.50 ± 1.79

MCQ Total

41.78 ± 6.78

44.60 ± 7.13

ASI-D

0.11 ± 0.02

0.16 ± 0.03

  1. Values given in means ± standard error.
  2. A African American, ASI-D Addiction Severity Index-Composite Score for Drug Use, ATYP atypical, AUDIT Alcohol Use Disorders Identification Test, C Caucasian (non-Hispanic), CDSS Calgary Depression Scale for Schizophrenia, C-SSRS Columbia Suicide Severity Rating-Scale, CUD cannabis use disorder, CUDIT-R Cannabis Use Disorder Identification Test-Revised, FTND Fagerstrom Test for Nicotine Dependence, H Hispanic/Latino, M More than one race, MCL Marijuana Contemplation Ladder, MCQ Marijuana Craving Questionnaire, MWC Marijuana Withdrawal Checklist, ng/mL nanograms per milliliter, O Other, PANSS Positive and Negative Symptom Scale, ppm parts per million, TOMM The Test of Memory Malingering, URICA University of Rhode Island Change Assessment Scale, WTAR IQ Wechsler Test of Adult Reading Intelligence Quotient.
  3. aValues are in numbers.
  4. bOther, n = 1 Indonesian.
  5. cScreen session.
Back to article page